story of the week
Clinical Management of Potential Toxicities and Drug Interactions Related to CDK4/6 Inhibitors in Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Oncologist 2017 Jul 13;[EPub Ahead of Print], LM Spring, ML Zangardi, B Moy, A BardiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.